| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 29 | 2025 | 674 | 5.560 |
Why?
|
| Heart | 11 | 2024 | 749 | 2.980 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 12 | 2021 | 16 | 2.360 |
Why?
|
| Cardiotoxicity | 3 | 2020 | 38 | 2.020 |
Why?
|
| Myocardium | 10 | 2025 | 1045 | 1.530 |
Why?
|
| Tissue Culture Techniques | 2 | 2024 | 68 | 1.530 |
Why?
|
| Biomimetics | 2 | 2022 | 18 | 1.420 |
Why?
|
| Myocardial Infarction | 7 | 2025 | 1102 | 1.400 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2022 | 234 | 1.290 |
Why?
|
| Heart Failure | 8 | 2025 | 2423 | 1.200 |
Why?
|
| Cardiomegaly | 6 | 2025 | 138 | 1.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2023 | 607 | 1.000 |
Why?
|
| Fibroblasts | 7 | 2025 | 921 | 0.890 |
Why?
|
| Calcium-Transporting ATPases | 4 | 2021 | 56 | 0.860 |
Why?
|
| Rats | 15 | 2025 | 3883 | 0.850 |
Why?
|
| Organ Culture Techniques | 2 | 2020 | 161 | 0.800 |
Why?
|
| Animals | 38 | 2025 | 36407 | 0.770 |
Why?
|
| Myocardial Ischemia | 2 | 2024 | 365 | 0.760 |
Why?
|
| Cell Cycle | 6 | 2024 | 626 | 0.760 |
Why?
|
| Signal Transduction | 18 | 2024 | 4906 | 0.750 |
Why?
|
| Nitric Oxide Synthase Type I | 3 | 2011 | 32 | 0.740 |
Why?
|
| Cellular Reprogramming | 5 | 2024 | 135 | 0.720 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 166 | 0.700 |
Why?
|
| Swine | 5 | 2024 | 1215 | 0.700 |
Why?
|
| Cardiotoxins | 1 | 2020 | 6 | 0.700 |
Why?
|
| Heart Ventricles | 3 | 2020 | 799 | 0.690 |
Why?
|
| Multienzyme Complexes | 2 | 2011 | 88 | 0.660 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 80 | 0.650 |
Why?
|
| GATA4 Transcription Factor | 4 | 2024 | 43 | 0.640 |
Why?
|
| Ventricular Function | 1 | 2019 | 94 | 0.600 |
Why?
|
| Cell Membrane | 3 | 2016 | 486 | 0.580 |
Why?
|
| Models, Biological | 4 | 2020 | 1534 | 0.580 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 293 | 0.550 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 271 | 0.540 |
Why?
|
| Dioxoles | 1 | 2016 | 11 | 0.530 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 41 | 0.520 |
Why?
|
| Benzamides | 1 | 2016 | 125 | 0.500 |
Why?
|
| Transcription Factors | 4 | 2024 | 2710 | 0.480 |
Why?
|
| Cyclic GMP | 3 | 2011 | 105 | 0.450 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1850 | 0.430 |
Why?
|
| Green Fluorescent Proteins | 2 | 2023 | 402 | 0.430 |
Why?
|
| Mice | 22 | 2025 | 18935 | 0.420 |
Why?
|
| Cyclic AMP | 2 | 2011 | 262 | 0.420 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 509 | 0.420 |
Why?
|
| Calmodulin | 2 | 2013 | 224 | 0.410 |
Why?
|
| Cell Proliferation | 7 | 2022 | 2553 | 0.400 |
Why?
|
| Stroke Volume | 3 | 2025 | 531 | 0.390 |
Why?
|
| p21-Activated Kinases | 3 | 2024 | 58 | 0.390 |
Why?
|
| Genes, Reporter | 1 | 2013 | 395 | 0.380 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 112 | 0.380 |
Why?
|
| Muscle Proteins | 3 | 2014 | 421 | 0.370 |
Why?
|
| Mammals | 2 | 2023 | 278 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 702 | 0.360 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 63 | 0.360 |
Why?
|
| Cells, Cultured | 8 | 2020 | 3174 | 0.340 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 801 | 0.330 |
Why?
|
| Enzyme Assays | 1 | 2010 | 12 | 0.330 |
Why?
|
| Humans | 37 | 2025 | 133564 | 0.330 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2020 | 164 | 0.310 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 121 | 0.300 |
Why?
|
| Cell Differentiation | 4 | 2024 | 2025 | 0.300 |
Why?
|
| Mice, Knockout | 9 | 2025 | 3989 | 0.300 |
Why?
|
| Calcium Signaling | 4 | 2015 | 255 | 0.290 |
Why?
|
| Calcineurin | 4 | 2014 | 101 | 0.290 |
Why?
|
| MEF2 Transcription Factors | 2 | 2019 | 41 | 0.290 |
Why?
|
| Ventricular Remodeling | 2 | 2025 | 190 | 0.260 |
Why?
|
| Membrane Proteins | 3 | 2025 | 1603 | 0.240 |
Why?
|
| Carboxypeptidases | 1 | 2025 | 20 | 0.240 |
Why?
|
| Pyruvate Kinase | 1 | 2025 | 11 | 0.240 |
Why?
|
| Aurintricarboxylic Acid | 2 | 2016 | 2 | 0.240 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2025 | 30 | 0.230 |
Why?
|
| Lipid Metabolism | 2 | 2025 | 382 | 0.230 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2024 | 30 | 0.230 |
Why?
|
| Glycolysis | 2 | 2022 | 172 | 0.230 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 484 | 0.220 |
Why?
|
| Dermoscopy | 1 | 2023 | 3 | 0.210 |
Why?
|
| Hair | 1 | 2023 | 29 | 0.210 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2021 | 478 | 0.210 |
Why?
|
| Hair Follicle | 1 | 2023 | 35 | 0.210 |
Why?
|
| Alopecia | 1 | 2023 | 41 | 0.210 |
Why?
|
| Stress, Mechanical | 1 | 2024 | 177 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2023 | 129 | 0.200 |
Why?
|
| Electric Stimulation | 1 | 2024 | 326 | 0.200 |
Why?
|
| Calcium | 3 | 2013 | 1146 | 0.200 |
Why?
|
| Renin | 1 | 2022 | 88 | 0.200 |
Why?
|
| Aldosterone | 1 | 2022 | 68 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2023 | 212 | 0.190 |
Why?
|
| Animals, Newborn | 3 | 2016 | 1044 | 0.190 |
Why?
|
| Apoptosis | 4 | 2020 | 1928 | 0.190 |
Why?
|
| Systole | 1 | 2022 | 206 | 0.190 |
Why?
|
| Genetic Therapy | 2 | 2024 | 733 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2022 | 118 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2022 | 104 | 0.190 |
Why?
|
| Endothelial Cells | 3 | 2023 | 544 | 0.190 |
Why?
|
| Culture Media | 1 | 2022 | 184 | 0.190 |
Why?
|
| Cell Division | 1 | 2023 | 773 | 0.190 |
Why?
|
| Autophagy | 1 | 2025 | 423 | 0.190 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 234 | 0.180 |
Why?
|
| Microsomes | 2 | 2013 | 55 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 615 | 0.180 |
Why?
|
| Heart Diseases | 2 | 2020 | 522 | 0.180 |
Why?
|
| Sphingosine | 2 | 2011 | 17 | 0.170 |
Why?
|
| Toxicity Tests | 1 | 2020 | 37 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4838 | 0.170 |
Why?
|
| Male | 14 | 2025 | 65798 | 0.170 |
Why?
|
| Technology | 1 | 2020 | 72 | 0.170 |
Why?
|
| Disease Models, Animal | 7 | 2025 | 4790 | 0.160 |
Why?
|
| Trastuzumab | 1 | 2020 | 154 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1310 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 381 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 202 | 0.160 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 516 | 0.160 |
Why?
|
| Sheep | 1 | 2020 | 237 | 0.160 |
Why?
|
| Regeneration | 2 | 2021 | 231 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2024 | 1255 | 0.160 |
Why?
|
| Doxorubicin | 1 | 2020 | 300 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 3 | 2014 | 336 | 0.150 |
Why?
|
| Cyclin B1 | 1 | 2018 | 8 | 0.150 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2527 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 544 | 0.150 |
Why?
|
| CDC2 Protein Kinase | 1 | 2018 | 35 | 0.140 |
Why?
|
| Malvaceae | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cytokinesis | 1 | 2018 | 26 | 0.140 |
Why?
|
| Antimutagenic Agents | 1 | 2017 | 2 | 0.140 |
Why?
|
| Models, Animal | 1 | 2020 | 483 | 0.140 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 78 | 0.140 |
Why?
|
| Cyclin D1 | 1 | 2018 | 123 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 67 | 0.140 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2017 | 38 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 231 | 0.130 |
Why?
|
| Adult | 4 | 2023 | 31842 | 0.130 |
Why?
|
| Plant Extracts | 1 | 2017 | 138 | 0.130 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 86 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 950 | 0.130 |
Why?
|
| Pressure | 1 | 2016 | 136 | 0.120 |
Why?
|
| Metabolomics | 1 | 2019 | 456 | 0.120 |
Why?
|
| Cell Shape | 1 | 2015 | 70 | 0.120 |
Why?
|
| Wnt Proteins | 1 | 2016 | 223 | 0.120 |
Why?
|
| Kidney | 1 | 2022 | 1418 | 0.120 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 241 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 77 | 0.120 |
Why?
|
| Antioxidants | 1 | 2017 | 377 | 0.110 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 21 | 0.110 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2014 | 3 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 1041 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2014 | 79 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 806 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2014 | 813 | 0.110 |
Why?
|
| Caveolae | 1 | 2013 | 9 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 703 | 0.110 |
Why?
|
| Propylene Glycols | 2 | 2011 | 19 | 0.100 |
Why?
|
| Cell Line | 4 | 2017 | 2839 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 616 | 0.100 |
Why?
|
| Adenoviridae | 2 | 2013 | 610 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 228 | 0.100 |
Why?
|
| Adenosine Diphosphate | 1 | 2013 | 54 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2016 | 809 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2429 | 0.100 |
Why?
|
| Female | 6 | 2023 | 71548 | 0.100 |
Why?
|
| Transcriptome | 1 | 2019 | 1137 | 0.100 |
Why?
|
| Contraception | 1 | 2013 | 61 | 0.100 |
Why?
|
| Aorta | 1 | 2016 | 561 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2014 | 271 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 2011 | 490 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 386 | 0.090 |
Why?
|
| Malaria | 1 | 2013 | 105 | 0.090 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2014 | 537 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 110 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 294 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2012 | 143 | 0.090 |
Why?
|
| Ion Transport | 1 | 2011 | 54 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 446 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 482 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 33 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2011 | 33 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1334 | 0.090 |
Why?
|
| Middle Aged | 3 | 2020 | 29264 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 144 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2014 | 833 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2013 | 970 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2009 | 70 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 124 | 0.070 |
Why?
|
| Gene Expression | 1 | 2013 | 1615 | 0.070 |
Why?
|
| Troponin I | 1 | 2009 | 117 | 0.070 |
Why?
|
| Protein Binding | 4 | 2019 | 1833 | 0.070 |
Why?
|
| NFATC Transcription Factors | 3 | 2014 | 48 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 2764 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 508 | 0.070 |
Why?
|
| Sarcolemma | 1 | 2006 | 23 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 100 | 0.060 |
Why?
|
| Myofibroblasts | 1 | 2025 | 79 | 0.060 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2024 | 18 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 1874 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3843 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2024 | 29 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2024 | 38 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 21641 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 716 | 0.050 |
Why?
|
| Diastole | 1 | 2023 | 185 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2014 | 19 | 0.050 |
Why?
|
| Phenylephrine | 2 | 2014 | 39 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2010 | 781 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 307 | 0.050 |
Why?
|
| Dependovirus | 1 | 2023 | 151 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 455 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 888 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 89 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2024 | 2162 | 0.050 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 27 | 0.050 |
Why?
|
| Heart Injuries | 1 | 2021 | 46 | 0.040 |
Why?
|
| Cell Plasticity | 1 | 2021 | 36 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 53 | 0.040 |
Why?
|
| Pertussis Toxin | 2 | 2011 | 29 | 0.040 |
Why?
|
| Fingolimod Hydrochloride | 2 | 2011 | 37 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 714 | 0.040 |
Why?
|
| Transfection | 2 | 2014 | 1090 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2024 | 869 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2011 | 991 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 124 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2010 | 644 | 0.040 |
Why?
|
| Comet Assay | 1 | 2017 | 13 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 90 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 97 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 60 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2019 | 369 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 497 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2010 | 716 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 130 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 364 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1396 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2016 | 34 | 0.030 |
Why?
|
| Fruit | 1 | 2017 | 237 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1704 | 0.030 |
Why?
|
| Machine Learning | 1 | 2019 | 334 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 433 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 65 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 292 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 351 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 320 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 313 | 0.030 |
Why?
|
| Hindlimb | 1 | 2014 | 85 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 128 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 109 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 773 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 143 | 0.030 |
Why?
|
| Chromatin | 1 | 2016 | 610 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1731 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 38 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 324 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 545 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3753 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2016 | 930 | 0.020 |
Why?
|
| Time Factors | 2 | 2014 | 6577 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2012 | 234 | 0.020 |
Why?
|
| Biotransformation | 1 | 2011 | 55 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 589 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 104 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 67 | 0.020 |
Why?
|
| Sphingolipids | 1 | 2011 | 35 | 0.020 |
Why?
|
| Coronary Occlusion | 1 | 2011 | 29 | 0.020 |
Why?
|
| Ischemia | 1 | 2014 | 384 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 917 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2011 | 184 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2009 | 5 | 0.020 |
Why?
|
| Sinoatrial Node | 1 | 2009 | 24 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 94 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 51 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 148 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 97 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1134 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 146 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 398 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 231 | 0.020 |
Why?
|
| Dystrophin | 1 | 2006 | 43 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 1004 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2899 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 2653 | 0.010 |
Why?
|